Zhirui Wang

Years Active: 2020-2023
Publications (10 Years): 5

University of Colorado Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Colorado Hospital Aug 01 2018

United States

Associate Profesoor :: Surgery

Publications

Zhaohui Wang, Jihong Ma, Huiping Zhang, Rashmi Ramakrishna, Danielle Mintzlaff, David W Mathes, Elizabeth A Pomfret, M Scott Lucia, Dexiang Gao, Bradley M Haverkos, Zhirui Wang
CCR4-IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T-cell lymphoma in a mouse CTCL model. FEBS open bio (2023)
Zhaohui Wang, Jihong Ma, Huiping Zhang, Rashmi Ramakrishna, Danielle Mintzlaff, David W Mathes, Elizabeth A Pomfret, M Scott Lucia, Dexiang Gao, Bradley M Haverkos, Zhirui Wang
CCR4-IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T-cell lymphoma in a mouse CTCL model. FEBS open bio (2023)
Zeng Qi, Yue Qiu, Zhaohui Wang, Huiping Zhang, Ling Lu, Yanqiu Liu, David Mathes, Elizabeth A Pomfret, Dexiang Gao, Shi-Long Lu, Zhirui Wang
A novel diphtheria toxin-based bivalent human EGF fusion toxin for treatment of head and neck squamous cell carcinoma. Molecular oncology 15 (4) (2021)
Xiong Xiong Chang, Kuohai Fan, Weijin Meng, Jianhua Guo, Dahai Zhao, Wei Yin, Hongquan Li, Zhirui Wang
Truncated Diphtheria Toxin DT390 Enhances the Humoral Immunogenicity of Porcine Circovirus Type 2 Capsid Antigen in Mice. Viral immunology 34 (7) (2021)
Haoyu Wang, Zhaohui Wang, Huiping Zhang, Zeng Qi, Ariel C Johnson, David Mathes, Elizabeth A Pomfret, Erin Rubin, Christene A Huang, Zhirui Wang
Bispecific human IL2-CCR4 immunotoxin targets human cutaneous T-cell lymphoma. Molecular oncology 14 (5) (2020)

Zhirui Wang.css-eqlu8i{font-size:small;padding-left:4px;}